SCHEMBL60954

SCHEMBL60954

Cc1ccc(F)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29367748 1.00
Bromide SCHEMBL28030872 0.97 ALDH1A1 (0.46)
Formaldehyde SCHEMBL27818208 0.92 HDAC1 (0.44)
SCHEMBL8819778 0.86 KMT2A (0.41)
SCHEMBL29089364 0.82 ACHE (0.48)
SCHEMBL26974251 0.82 AKR1C3 (0.54)
SCHEMBL29475251 0.81
SCHEMBL13906282 0.79 TNKS2 (0.50)
SCHEMBL12500 0.79
SCHEMBL18867943 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6603 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4592399-B1 COMPOSITIONS, KITS AND METHODS FOR ISOLATING TARGET POLYNUCLEOTIDES DNAE DIAGNOSTICS LTD (GB) 2026-03-11 EP claimed
US-20260058209-A1 ELECTROLYTE COMPOSITION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY CONTAINING THE SAME HYUNDAI MOTOR CO LTD (KR) 2026-02-26 US claimed
EP-4634200-A1 ENZYMATIC SYNTHESIS OF NTP AND NQP Codexis, Inc. (US) 2025-10-22 EP claimed
WO-2025217135-A1 RNA LIGATION METHODS AND PRODUCTS CONVERGENCE BIO, INC. (US) 2025-10-16 WO claimed
US-20250283078-A1 RNA COMPOSITIONS AND THERAPEUTIC METHODS THEREOF BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2025-09-11 US claimed
US-12334502-B2 Electrolytes for lithium-containing battery cells APPLE INC. (US) 2025-06-17 US claimed
WO-2025081113-A1 ENGINEERED ADENOSINE KINASE VARIANTS CODEXIS, INC. (US) 2025-04-17 WO claimed
WO-2025081095-A1 ENGINEERED ACETATE KINASE VARIANTS CODEXIS, INC. (US) 2025-04-17 WO claimed
US-20250122486-A1 ENGINEERED ADENOSINE KINASE VARIANTS CODEXIS, INC. 2025-04-17 US claimed
US-20250122487-A1 ENGINEERED ACETATE KINASE VARIANTS CODEXIS, INC. 2025-04-17 US claimed
US-20030181390-A1 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues XENOPORT, INC. 2003-09-25 US claimed
US-20030091266-A1 Optical systems and refractive index-matching compositions AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD. (SG) 2003-05-15 US claimed
WO-2002100344-A2 AMINO ACID CONJUGATES PROVIDING FOR SUSTAINED SYSTEMIC CONCENTRATIONS OF GABA ANALOGUES XENOPORT, INC. (US) 2002-12-19 WO claimed
US-6495540-B2 HEXAHYDROAZEPINE-2-ONE DERIVATIVE AS BETA-AMYLOID INHIBITOR BRISTOL - MYERS SQUIBB PHARMA COMPANY 2002-12-17 US claimed
US-20020022227-A1 Morphatides: novel shape and structure libraries Life Technologies Corporation 2002-02-21 US claimed
US-20020010172-A1 Lactams as inhibitors of A-beta protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-01-24 US claimed
US-6060453-A Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose GREENWICH PHARMACEUTICALS INCORPORATED (US) 2000-05-09 US claimed
EP-0954600-A2 MORPHATIDES: NOVEL SHAPE AND STRUCTURE LIBRARIES Morphagen (US) 1999-11-10 EP claimed
WO-1998016661-A2 MORPHATIDES: NOVEL SHAPE AND STRUCTURE LIBRARIES MORPHAGEN (US) 1998-04-23 WO claimed
US-5594022-A CARBAMATES WARNER-LAMBERT COMPANY (US) 1997-01-14 US claimed